Valuation: Gujarat Themis Biosyn Limited

Capitalization 2.48TCr 26Cr 22Cr 20Cr 19Cr 36Cr 36Cr 243.84Cr 94Cr 1.18TCr 97Cr 95Cr 4.1TCr P/E ratio 2024
48.7x
P/E ratio 2025 62.9x
Enterprise value 2.5TCr 26Cr 22Cr 20Cr 20Cr 36Cr 36Cr 245.69Cr 95Cr 1.19TCr 98Cr 96Cr 4.13TCr EV / Sales 2024
16.9x
EV / Sales 2025 20.5x
Free-Float
28.02%
Yield 2024
0.25%
Yield 2025 0.24%
1 day-1.22%
1 week-6.75%
Current month+2.14%
1 month+16.31%
3 months+17.45%
6 months-17.03%
Current year-16.02%
1 week 359.3
Extreme 359.3
389.05
1 month 313.1
Extreme 313.1
412
Current year 225.75
Extreme 225.75
440.85
1 year 225.75
Extreme 225.75
479.45
3 years 97.2
Extreme 97.2
479.45
5 years 33.33
Extreme 33.3333
479.45
10 years 3.75
Extreme 3.7533
479.45
Manager TitleAgeSince
Chief Executive Officer 51 01/07/2025
Director of Finance/CFO - 01/04/2026
Compliance Officer - 03/09/2024
Director TitleAgeSince
Director/Board Member 69 26/07/2024
Chairman 77 25/05/1992
Director/Board Member 72 25/07/2011
Change 5d. change 1-year change 3-years change Capi.($)
-1.22%-6.75%+8.53%+246.21% 42Cr
+0.81%+1.64%+8.26%+100.67% 4.7TCr
+1.47%+3.73%+71.69%+132.75% 3.73TCr
-0.32%+6.32%-4.52%+55.00% 1.21TCr
+2.02%+7.62%+12.07%+95.01% 1.06TCr
+1.22%0.00%+35.33%+120.35% 908.74Cr
-0.81%+2.07%+66.64%-3.12% 750.28Cr
-0.32%-0.55%+19.00%+56.20% 739.23Cr
-0.63%-1.71%+60.56%+282.02% 684.14Cr
-4.20%-3.96%+162.16%+489.67% 602.31Cr
Average -0.20%+0.70%+43.97%+157.47% 1.44TCr
Weighted average by Cap. +0.58%+1.98%+38.08%+123.57%

Financials

2024 2025
Net sales 169.82Cr 1.77Cr 1.52Cr 1.39Cr 1.33Cr 2.44Cr 2.48Cr 17Cr 6.47Cr 81Cr 6.64Cr 6.5Cr 280.86Cr 150.8Cr 1.57Cr 1.35Cr 1.24Cr 1.18Cr 2.16Cr 2.2Cr 15Cr 5.74Cr 72Cr 5.9Cr 5.77Cr 249.4Cr
Net income 59Cr 61.67L 53.06L 48.52L 46.29L 84.86L 86.26L 5.82Cr 2.25Cr 28Cr 2.31Cr 2.26Cr 98Cr 49Cr 50.83L 43.74L 40L 38.16L 69.96L 71.11L 4.8Cr 1.86Cr 23Cr 1.91Cr 1.87Cr 81Cr
Net Debt -12Cr -12.31L -10.6L -10L -9L -16.95L -17.23L -1.16Cr -44.98L -5.61Cr -46.21L -45.22L -20Cr 19Cr 19.57L 16.84L 15.4L 14.69L 26.93L 27.38L 1.85Cr 71.48L 8.91Cr 73.44L 71.87L 31Cr
Logo Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company is focused on the business of manufacturing and sale of finished active pharmaceutical ingredients (API) products by fermentation process. The Company operates through pharmaceuticals segment. Its product portfolio comprises Rifamycin-S and Lovastatin. The Company is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin (an Antibiotic used for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.) and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin (this is an Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy).
Employees
221
Date Price Change Volume
15/26/15 371.55 -1.22% 8,451
14/26/14 376.15 -0.36% 5,301
13/26/13 377.50 +4.24% 4,967
12/26/12 362.15 -6.34% 14,566
11/26/11 386.65 -2.96% 21,413
  1. Stock Market
  2. Equities
  3. 506879 Stock